Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorin

About this trial

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Both genders.

Adult subjects.

Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.

The subject is willing to comply with the required follow-up visits as per protocol.

Disqualifiers

Subjects with active infection or sepsis or osteomyelitis.

Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis.

Subject with marked bone loss or bone absorption.

Subject with metabolic disorders which may impair bone formation or bone quality.

Trial population

Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Bipolar i and cemented stem (Océane+ or Meije)

    Device

    Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint

Treatment groups

368 Participants
are divided into 1 treatment group
Group A: Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)1 intervention

Trial outcomes

Primary outcomes

1

Evaluation of safety of the study devices at 2 years after a hip hemiarthroplasty surgery.

Intraoperative and postoperative adverse events (hip, device or procedure related) will be recorded.

Time frame
2 years

Secondary outcomes

1

Evaluation of mid-term and long-term safety of the study devices up to 10 years.

Intraoperative and postoperative adverse events (hip, device or procedure related) will be recorded.

Time frame
10 years
2

Evaluation of study devices performance and benefit through patient's mobility from baseline to 10-year FU.

Parker Mobility Score

Time frame
10 years
3

Evaluation of study devices performance and benefit through patient's quality of life from baseline to 10-year FU.

EQ5D-5L

Time frame
10 years
4

Radiographic analysis to detect acetabular erosion

Acetabular erosion measured comparing immediate post-operative X-rays (baseline) to 2-year follow up and classified according to the criteria of Baker et al.

Time frame
2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.